reported that MAPK14 is highly active in clear cell renal cell carcinoma, promoting tumour proliferation and migration by regulating the cell division cycle protein CDC25B; inhibiting MAPK14 significantly reduces tumour cell proliferation and migration. Here, CDC25B is linked to clear cell renal carcinoma.